ONLINE DATABASE SEARCH - HIV-LS-287
1. 42606 HIV-LS-287; SCIFIND-HIV-01/07/2004
Indole, azaindole and related heterocyclic sulfonylureido piperazine derivatives((Bristol-Myers Squibb Company, USA)
Kadow, John F, Regueiro-Ren, Alicia, and Xue, Qiufen May
PATENT: WO 2004000210 A2; ISSUE DATE: 20031231
APPLICATION: 2003; PP: 106 pp.
2. 42607 HIV-LS-287; SCIFIND-HIV-01/07/2004
Antiviral drugs: PA-457: a potent HIV inhibitor that disrupts core condensation by targeting a late step in Gag processing
Anon
Nature Reviews Drug Discovery 2003. 2(12): 948
3. 42608 HIV-LS-287; WOS-HIV-1/5/2004
Viral protein U counteracts a human host cell restriction that inhibits HIV-1 particle production
Varthakavi, V, Smith, RM, Bour, SP, Strebel, K, and Spearman, P
P NATL ACAD SCI USA 2003. 100(25): 15154-15159
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000187227200098
4. 42609 HIV-LS-287; SCIFIND-HIV-01/07/2004
Preparation of 2,2-bis(hydroxymethyl)cyclopropylidenemethyl-purines and -pyrimidines as antiviral agents ((Wayne State University, USA, The Regents of the University of Michigan, and Drach, john C.)
Zemlicka, Jiri, Zhou, Shaoman, and Drach, John C
PATENT: WO 2003104440 A2; ISSUE DATE: 20031218
APPLICATION: 2003; PP: 45 pp.
5. 42610 HIV-LS-287; WOS-HIV-1/5/2004
Synthesis and studies of 3'-C-trifluoromethyl-beta-D-ribonucleosides bearing the five naturally occurring nucleic acid bases
Jeannot, F, Gosselin, G, and Mathe, C
NUCLEOS NUCLEOT NUCL 2003. 22(12): 2195-2202
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000187216100010
6. 42611 HIV-LS-287; SCIFIND-HIV-01/07/2004
Use of defensins as antiviral agents ((Ciphergen Biosystems, Inc. USA, Aaron Diamond Aids Research Center, and The Rockefeller University))
Zhang, Linqi, Ho, David D, Caffrey, Rebecca E, Dalmasso, Enrique A, and Mei, Jianfeng
PATENT: WO 2003101394 A2; ISSUE DATE: 20031211
APPLICATION: 2003; PP: 107 pp.
7. 42612 HIV-LS-287; WOS-HIV-1/5/2004
Chemokine-induced cell death in CCR5-expressing neuroblastoma cells
Cartier, L, Dubois-Dauphin, M, Hartley, O, Irminger-Finger, I, and Krause, KH
J NEUROIMMUNOL 2003. 145(1-2): 27-39
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000187219800004
8. 42613 HIV-LS-287; SCIFIND-HIV-01/07/2004
Anti-CCR5 antibody and conjugates for treating human immunodeficiency virus 1 infection((USA))
Olson, William C, Maddon, Paul J, Tsurushita, Naoya, Hinton, Paul R, and Vasquez, Maximiliano
PATENT: US 20030228306 A1; ISSUE DATE: 20031211
APPLICATION: 2003-43803; PP: 52 pp., Cont.-in-part of U.S. Provisional Ser. No. 358,886.
9. 42614 HIV-LS-287; SCIFIND-HIV-01/07/2004
Preparation of pyrrolinylbenzothiadiazine dioxides as antiviral agents((Smithkline Beecham Corporation, USA)
Duffy, Kevin J, Evans, Karen A, Fitch, Duke M, Gates, Adam T, Johnston, Victor K, and Sarisky, Robert T
PATENT: WO 2003099801 A1; ISSUE DATE: 20031204
APPLICATION: 2003; PP: 89 pp.
10. 42615 HIV-LS-287; SCIFIND-HIV-01/07/2004
Preparation of calixarene-derivatives having anti-viral activity((Aids Care Pharma, Limited Ire.)
Coveney, Donal and Costello, Benjamin
PATENT: EP 1367044 A1; ISSUE DATE: 20031203
APPLICATION: 2003-11002; PP: 22 pp.
11. 42616 HIV-LS-287; WOS-HIV-1/5/2004
HIV-1 preferentially binds receptors copatched with cell-surface elastase
Bristow, CL, Mercatante, DR, and Kole, R
BLOOD 2003. 102(13): 4479-4486
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000187122000044
12. 42617 HIV-LS-287; SCIFIND-HIV-01/07/2004
Stable helical viral C peptides for inhibiting viral or HIV-1 entry and drug screening((Whitehead Institute for Biomedical Research, USA)
Sia, Samuel K and Kim, Peter S
PATENT: US 2003219451 A1; ISSUE DATE: 20031127
APPLICATION: 2002-21259; PP: 27 pp.
13. 42618 HIV-LS-287; SCIFIND-HIV-01/07/2004
Use of a small molecule CCR5 inhibitor in macaques to treat simian immunodeficiency virus infection or prevent simian-human immunodeficiency virus infection
Veazey, Ronald S, Klasse, Per Johan, Ketas, Thomas J, Reeves, Jacqueline D, Piatak, Michael Jr, Kunstman, Kevin, Kuhmann, Shawn E, Marx, Preston A, Lifson, Jeffrey D, Dufour, Jason, Mefford, Megan, Pandrea, Ivona, Wolinsky, Steven M, Doms, Robert W, DeMartino, Julie A, Siciliano, Salvatore J, Lyons, Kathy, Springer, Martin S, and Moore, John P
Journal of Experimental Medicine 2003. 198(10): 1551-1562
14. 42619 HIV-LS-287; SCIFIND-HIV-01/07/2004
Therapeutic Drug Monitoring of the HIV/AIDS Drugs Abacavir, Zidovudine, Efavirenz, Nevirapine, Indinavir, Lopinavir, and Nelfinavir
Donnerer, J, Kronawetter, M, Kapper, A, Haas, I, and Kessler, HH
Pharmacology 2003. 69(4): 197-204
15. 42620 HIV-LS-287; SCIFIND-HIV-01/07/2004
Preparation of piperazine derivatives as antiviral agents((Bristol-Myers Squibb Company, USA)
Wang, Tao, Wallace, Owen B, Meanwell, Nicholas A, Kadow, John F, Zhang, Zhongxing, and Yang, Zhong
PATENT: WO 2003092695 A1; ISSUE DATE: 20031113
APPLICATION: 2003; PP: 121 pp.
16. 42621 HIV-LS-287; SCIFIND-HIV-01/07/2004
Preparation of phosphonate analogs of HIV protease inhibitors and methods for identifying anti-HIV therapeutic compounds((Gilead Sciences, Inc. USA)
Birkus, Gabriel, Chen, James M, Chen, Xiaowu, Cihlar, Tomas, Eisenberg, Eugene J, Hatada, Marcos, He, Gong-Xin, Kim, Choung U, Lee, William A, McDermott, Martin J, and Swaminathan, Sundaramoorthi
PATENT: WO 2003090691 A2; ISSUE DATE: 20031106
APPLICATION: 2003; PP: 814 pp.
17. 42622 HIV-LS-287; SCIFIND-HIV-01/07/2004
Antiviral inhibitions of capsid proteins((University of Maryland, Baltimore County USA)
Summers, Michael F, Tang, Chun, and Huang, Mingjun
PATENT: WO 2003089615 A2; ISSUE DATE: 20031030
APPLICATION: 2003; PP: 59 pp.
18. 42623 HIV-LS-287; SCIFIND-HIV-01/07/2004
Design and synthesis of phosphonoacetic acid (PPA) ester and amide bioisosters of ribofuranosylnucleo-side diphosphates as potential ribonucleotide reductase inhibitors and evaluation of their enzyme inhibitory, cytostatic and antiviral activity
Manfredini, Stefano, Solaroli, Nicola, Angusti, Angela, Nalin, Federico, Durini, Elisa, Vertuani, Silvia, Pricl, Sabrina, Ferrone, Marco, Spadari, Silvio, Focher, Federico, Verri, Annalisa, De Clercq, Erik, and Balzarini, Jan
Antiviral Chemistry & Chemotherapy 2003. 14(4): 183-194
19. 42624 HIV-LS-287; SCIFIND-HIV-01/07/2004
Cytostatic activity of antiviral acyclic nucleoside phosphonates in rodent lymphocytes
Zidek, Zdenek, Potmesil, Petr, and Holy, Antonin
Toxicology and Applied Pharmacology 2003. 192(3): 246-253
20. 42625 HIV-LS-287; WOS-HIV-1/10/2004
HIV-1 transmission and cytokine-induced expression of DC-SIGN in human monocyte-derived macrophages
Chehimi, J, Luo, Q, Azzoni, L, Shawver, L, Ngoubilly, N, June, R, Jerandi, G, Farabaugh, M, and Montaner, LJ
J LEUKOCYTE BIOL 2003. 74(5): 757-763
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000187392400016
21. 42626 HIV-LS-287; WOS-HIV-1/10/2004
Drug-loaded red blood cell-mediated clearance of HIV-1 macrophage reservoir by selective inhibition of STAT1 expression
Magnani, M, Balestra, E, Fraternale, A, Aquaro, S, Paiardini, M, Cervasi, B, Casabianca, A, Garaci, E, and Pernot, CF
J LEUKOCYTE BIOL 2003. 74(5): 764-771
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000187392400017
22. 42627 HIV-LS-287; WOS-HIV-1/10/2004
Macrophages and lymphocytes differentially modulate the ability of RANTES to inhibit HIV-1 infection
Gross, E, Amella, CA, Pompucci, L, Franchin, G, Sherry, B, and Schmidtmayerova, H
J LEUKOCYTE BIOL 2003. 74(5): 781-790
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000187392400019
23. 42628 HIV-LS-287; SCIFIND-HIV-01/07/2004
N'-{n-[3-oxo-20[29]lupen-28-oyl]-9-aminononanoyl}-3-amino-3-phenylpropionic acid eliciting immuno-stimulating and antiviral activity((Novosibirskii Institut Organicheskoi Khimii im. N. N. Vorozhtsova SO RAN, Russia and Gosudarstvennyi Nauchnyi Tsentr Virusologii i Biotekhnologii \"Vektor\"))
Tolstikov, GA, Petrenko, NI, Elantseva, NV, Shul'ts, EE, Plyasunova, OA, Il'icheva, TN, Borisova, OA, Pronyaeva, TR, and Pokrovskii, AG
PATENT: RU 2211843 C1; ISSUE DATE: 20030910
APPLICATION: 2002-36802; PP: No pp. given
24. 42629 HIV-LS-287; WOS-HIV-1/10/2004
Selective inactivation of CCR5 and decreased infectivity of R5 HIV-1 strains mediated by opioid-induced heterologous desensitization
Szabo, I, Wetzel, MA, Zhang, N, Steele, AD, Kaminsky, DE, Chen, CG, Liu-Chen, LY, Bednar, F, Henderson, EE, Howard, OMZ, Oppenheim, JJ, and Rogers, TJ
J LEUKOCYTE BIOL 2003. 74(6): 1074-1082
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000187392600015
25. 42630 HIV-LS-287; SCIFIND-HIV-01/07/2004
Pokeweed antiviral protein polypeptides with antiviral activity((Parker Hughes Institute, USA)
Uckun, Faith M
PATENT: WO 2003106479 A2; ISSUE DATE: 20031224
APPLICATION: 2003; PP: 62 pp.
26. 42631 HIV-LS-287; WOS-HIV-1/10/2004
Combinational therapy for potential HIV-1 eradication and vaccination
Lin, SL and Ying, SY
INT J ONCOL 2004. 24(1): 81-88
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000187359500010
27. 42632 HIV-LS-287; WOS-HIV-1/10/2004
Pharmacodynamics and clinical use of anti-HIV drugs
Preston, SL, Piliero, PJ, and Drusano, GL
INFECT DIS CLIN N AM 2003. 17(3): 651-+
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000187439100010
28. 42633 HIV-LS-287; SCIFIND-HIV-01/07/2004
Antiviral Activity of Enteric-Coated Didanosine, Stavudine, and Nelfinavir Versus Zidovudine Plus Lamivudine and Nelfinavir
Gathe, Joseph Jr, Badaro, Roberto, Grimwood, Ashraf, Abrams, Lori, Klesczewski, Ken, Cross, Anne, and McLaren, Colin
JAIDS, Journal of Acquired Immune Deficiency Syndromes 2002. 31(4): 399-403
29. 42634 HIV-LS-287; WOS-HIV-1/10/2004
HIV-1 integrase can process a 3 '-end crosslinked substrate - Implications of DNA end-fraying requirement during the 3 '-processing reaction
Agapkina, J, Smolov, M, Zubin, E, Mouscadet, JF, and Gottikh, M
EUR J BIOCHEM 2004. 271(1): 205-211
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000187449200020
30. 42635 HIV-LS-287; SCIFIND-HIV-01/07/2004
Antiviral drug development and the impact of drug resistance
Darby, Graham
Symposium of the Society for General Microbiology 2001. 60th(New Challenges to Health: The Threat of Virus Infection): 311-339
31. 42636 HIV-LS-287; SCIFIND-HIV-01/07/2004
Substituted 1,3-oxathiolanes with antiviral properties((Biochem Pharma Inc., Can.)
Mansour, Tarek S and Jin, Haolun
PATENT: US 6228860 B1; ISSUE DATE: 20010508
APPLICATION: 96-63195; PP: 20 pp., Cont.-in-part of U.S. 5,587,480.
32. 42637 HIV-LS-287; PUBMED-HIV-1/12/2004
Isolation, structure, and HIV-1-integrase inhibitory activity of structurally diverse fungal metabolites
Singh, SB, Jayasuriya, H, Dewey, R, Polishook, JD, Dombrowski, AW, Zink, DL, Guan, Z, Collado, J, Platas, G, Pelaez, F, Felock, PJ, and Hazuda, DJ
J Ind Microbiol Biotechnol 2004
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=14714192&dopt=abstract
33. 42638 HIV-LS-287; SCIFIND-HIV-01/07/2004
Mutations conferring resistance to zidovudine diminish the antiviral effect of stavudine plus didanosine
Izopet, J, Bicart-See, A, Pasquier, C, Sandres, K, Bonnet, E, Marchou, B, Puel, J, and Massip, P
Journal of Medical Virology 99. 59(4): 507-511
34. 42639 HIV-LS-287; SCIFIND-HIV-01/07/2004
Peptide, nucleic acid encoding it, recombinant vectors, transformants, manufacture of the peptide, and antiviral agents((Japan))
Okamoto, Tamotsu
PATENT: JP 11322794 A2; ISSUE DATE: 19991124
APPLICATION: 98-3637; PP: 7 pp.
35. 42640 HIV-LS-287; SCIFIND-HIV-01/07/2004
Antiviral agents for control of human immunodeficiency virus((Nippon Eye Drop Kenkyusho K. K., Japan)
Nozaki, Junko, Numata, Ryuichi, and Ito, Koichi
PATENT: JP 11147806 A2; ISSUE DATE: 19990602
APPLICATION: 97-50360; PP: 4 pp.
36. 42641 HIV-LS-287; SCIFIND-HIV-01/07/2004
Preparation of 2-mercapto-N-(5-amino-1,2,4-triazol-3-yl)benzenesulfonamides as anti-AIDS and antitumor agents ((Akademia Medyczna, Pol.)
Brzozowski, Zdzislaw
PATENT: PL 173244 B1; ISSUE DATE: 19980227
APPLICATION: 93-39608; PP: 7 pp.
37. 42642 HIV-LS-287; PUBMED-HIV-1/12/2004
New bicyclam-GalCer analogue conjugates: synthesis and in vitro anti-HIV activity
Daoudi, JM, Greiner, J, Aubertin, AM, and Vierling, P
Bioorg Med Chem Lett 2004. 14(2): 495-8
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=14698189&dopt=abstract
38. 42643 HIV-LS-287; PUBMED-HIV-1/12/2004
2,6-Bis(3,4,5-trihydroxybenzylydene) derivatives of cyclohexanone. novel potent HIV-1 integrase inhibitors that prevent HIV-1 multiplication in cell-based assays
Costi, R, Santo, RD, Artico, M, Massa, S, Ragno, R, Loddo, R, La, Colla M, Tramontano, E, La, Colla P, and Pani, A
Bioorg Med Chem 2004. 12(1): 199-215
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=14697785&dopt=abstract
39. 42644 HIV-LS-287; PUBMED-HIV-1/12/2004
Water-soluble prodrugs of dipeptide HIV protease inhibitors based on O-->N intramolecular acyl migration: Design, synthesis and kinetic study
Hamada, Y, Matsumoto, H, Yamaguchi, S, Kimura, T, Hayashi, Y, and Kiso, Y
Bioorg Med Chem 2004. 12(1): 159-70
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=14697781&dopt=abstract
40. 42645 HIV-LS-287; PUBMED-HIV-1/12/2004
Small-Molecule Inhibition of Human Immunodeficiency Virus Type 1 Replication by Specific Targeting of the Final Step of Virion Maturation
Zhou, J, Yuan, X, Dismuke, D, Forshey, BM, Lundquist, C, Lee, KH, Aiken, C, and Chen, CH
J Virol 2004. 78(2): 922-929
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=14694123&dopt=abstract
41. 42646 HIV-LS-287; PUBMED-HIV-1/12/2004
Role of the Ectodomain of the gp41 Transmembrane Envelope Protein of Human Immunodeficiency Virus Type 1 in Late Steps of the Membrane Fusion Process
Bar, S and Alizon, M
J Virol 2004. 78(2): 811-20
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=14694113&dopt=abstract
42. 42647 HIV-LS-287; PUBMED-HIV-1/12/2004
Inhibition of Human Immunodeficiency Virus Type 1 Entry in Cells Expressing gp41-Derived Peptides
Egelhofer, M, Brandenburg, G, Martinius, H, Schult-Dietrich, P, Melikyan, G, Kunert, R, Baum, C, Choi, I, Alexandrov, A, and Von, Laer D
J Virol 2004. 78(2): 568-575
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=14694088&dopt=abstract
43. 42648 HIV-LS-287; PUBMED-HIV-1/12/2004
In vitro evaluation of nonnucleoside reverse transcriptase inhibitors UC-781 and TMC120-R147681 as human immunodeficiency virus microbicides
Van, Herrewege Y, Michiels, J, Van, Roey J, Fransen, K, Kestens, L, Balzarini, J, Lewi, P, Vanham, G, and Janssen, P
Antimicrob Agents Chemother 2004. 48(1): 337-9
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=14693562&dopt=abstract
44. 42649 HIV-LS-287; PUBMED-HIV-1/12/2004
Single-dose and steady-state pharmacokinetics of tenofovir disoproxil fumarate in human immunodeficiency virus-infected children
Hazra, R, Balis, FM, Tullio, AN, DeCarlo, E, Worrell, CJ, Steinberg, SM, Flaherty, JF, Yale, K, Poblenz, M, Kearney, BP, Zhong, L, Coakley, DF, Blanche, S, Bresson, JL, Zuckerman, JA, and Zeichner, SL
Antimicrob Agents Chemother 2004. 48(1): 124-9
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=14693529&dopt=abstract
45. 42650 HIV-LS-287; PUBMED-HIV-1/12/2004
Genotypic resistance of antiretroviral drugs among drug-naive HIV type 1 patients with the background of long-term access-easy zidovudine therapy
Park, SW, Kim, HB, Choi, YJ, Kim, NJ, Oh, MD, and Choe, KW
AIDS Res Hum Retroviruses 2003. 19(11): 1039-43
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=14686324&dopt=abstract
46. 42651 HIV-LS-287; PUBMED-HIV-1/12/2004
Thermolytic carbonates for potential 5'-hydroxyl protection of deoxyribonucleosides
Chmielewski, MK, Marchan, V, Cieslak, J, Grajkowski, A, Livengood, V, Munch, U, Wilk, A, and Beaucage, SL
J Org Chem 2003. 68(26): 10003-12
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=14682694&dopt=abstract
47. 42652 HIV-LS-287; PUBMED-HIV-1/12/2004
Low level expression of the HIV-1 Nef protein in transiently transfected COS-1 cells in culture
Hartz, PA, McMiller, T, Scott-Wright, D, and Samuel, KP
Cell Mol Biol (Noisy-le-grand) 2003. 49(7): 1101-7
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=14682392&dopt=abstract
48. 42653 HIV-LS-287; PUBMED-HIV-1/12/2004
Meeting notes from the 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). New CCR5 antagonist shows antiretroviral effect
Feinberg, J
AIDS Clin Care 2003. 15(11): 94-5
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=14682273&dopt=abstract
49. 42654 HIV-LS-287; PUBMED-HIV-1/12/2004
Substitution for protease inhibitors in HIV therapy
Hirschel, B
N Engl J Med 2003. 349(25): 2460-1; author reply 2460-1
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=14681514&dopt=abstract
50. 42655 HIV-LS-287; PUBMED-HIV-1/12/2004
The integrase of the human immunodeficiency virus as a novel target for the antiviral therapy of AIDS
Witvrouw, M and Debyser, Z
Verh K Acad Geneeskd Belg 2003. 65(5): 325-34
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=14671848&dopt=abstract